An 80-year-old male presented to the tertiary center with multiple episodes of syncope, exertional chest pain, and dyspnea (New York Heart Association [NYHA] class III). Transthoracic echocardiography (TTE) showed a severely calcified aortic valve with mean gradient of 58 mm Hg and preserved left ventricular ejection fraction. The patient was diagnosed with severe aortic stenosis with aortic valve area of 0.68 cm2. Coronary angiography showed that the left circumflex artery (LCx) originated from the right sinus of Valsalva with a retroaortic course as seen in Figure 1A.
During the same procedure, the patient underwent left anterior descending artery and anomalous left circumflex artery percutaneous coronary intervention (PCI) (Supplementary material, Videos S1, S2).
Based on cardiac computed tomography measurements (Figure 1B) and cardiac anatomy (Supplementary material, Videos S3, S4), the Heart Team decided to proceed with ACURATE neo2TM M (Boston Scientific, Marlborough, MA, US) transcatheter heart valve (THV) implantation using a transfemoral approach. The selection of this valve was based on lower radial force compared with other THV platforms (avoidance of extrinsic compression of the LCx artery), feasible commissural alignment, and good coronary access after valve implantation .
The aortic valve was predilated with a 22 × 40 mm NuCLEUSTM balloon (NuMED Canada Inc, ON, Canada) under rapid pacing, and selective coronary angiography was performed simultaneously. As seen in Figure 1C and Supplementary material, Video S5, the anomalous LCx was compressed at the level where it crosses the aortic annulus, therefore, a stent with extra support wire was advanced into the distal part of the LCx for additional protection from coronary occlusion during THV implantation. ACURATE neo2TM M was implanted in the optimal high position using the “commissural alignment” technique (Supplementary material, Video S6–S7). Selective angiography confirmed the widely potent LCx (Figure 1D and Supplementary material, Video S8), thus the wire and stent were removed. The final result can be seen in the Supplementary material, Video S9. The post-TAVI transthoracic echocardiography showed a well-functioning implanted aortic valve with no residual gradient or paravalvular leak.
Obstruction of coronary arteries after TAVI is an uncommon complication with a prevalence of around 0.5%–1%. These obstructions are believed to be caused by the compression of the coronary ostium due to calcification of native valve leaflets . However, a different risk arises especially when a patient has abnormal coronary arteries anatomy, and that is extrinsic compression from the stretching force of the expanding valve if the artery is adjacent to the aortic annulus . To prevent such complications, computed tomography scans together with careful selection of valve type based on anatomic, technical aspects, and operators’ experience with particular THV platforms are crucial. Also, coronary protection should be considered .
No guidelines specifically for TAVI in patients with anomalous coronary arteries exist now, therefore, Heart Teams should evaluate each patient’s case individually and choose the safest strategy to avoid complications, as illustrated in this case.
Supplementary material is available at https://journals.viamedica.pl/kardiologia_polska
Conflict of interest: None declared.
Open access: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, which allows downloading and sharing articles with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. For commercial use, please contact the journal office at firstname.lastname@example.org.